ECRG4 acts as a TSG in breast cancer, and may induce apoptosis via the mitochondrial apoptotic pathway and block the cell cycle at the G0/G1 phase by regulating the Cyclin–CDK–CKI network. Here, ECRG4 is linked to breast cancer.